Press brief by Max Topp, MD of the University of Würzburg, Würzburg, Germany, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.
"Immunotherapy delivered by blinatumomab improves survival in acute lymphoblastic leukaemia patients "
